Correlation Between Ventyx Biosciences and Terns Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Ventyx Biosciences and Terns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ventyx Biosciences and Terns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ventyx Biosciences and Terns Pharmaceuticals, you can compare the effects of market volatilities on Ventyx Biosciences and Terns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ventyx Biosciences with a short position of Terns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ventyx Biosciences and Terns Pharmaceuticals.
Diversification Opportunities for Ventyx Biosciences and Terns Pharmaceuticals
0.46 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Ventyx and Terns is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Ventyx Biosciences and Terns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Terns Pharmaceuticals and Ventyx Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ventyx Biosciences are associated (or correlated) with Terns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Terns Pharmaceuticals has no effect on the direction of Ventyx Biosciences i.e., Ventyx Biosciences and Terns Pharmaceuticals go up and down completely randomly.
Pair Corralation between Ventyx Biosciences and Terns Pharmaceuticals
Given the investment horizon of 90 days Ventyx Biosciences is expected to under-perform the Terns Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Ventyx Biosciences is 1.01 times less risky than Terns Pharmaceuticals. The stock trades about -0.3 of its potential returns per unit of risk. The Terns Pharmaceuticals is currently generating about -0.24 of returns per unit of risk over similar time horizon. If you would invest 699.00 in Terns Pharmaceuticals on August 24, 2024 and sell it today you would lose (128.00) from holding Terns Pharmaceuticals or give up 18.31% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ventyx Biosciences vs. Terns Pharmaceuticals
Performance |
| Timeline |
| Ventyx Biosciences |
| Terns Pharmaceuticals |
Ventyx Biosciences and Terns Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ventyx Biosciences and Terns Pharmaceuticals
The main advantage of trading using opposite Ventyx Biosciences and Terns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ventyx Biosciences position performs unexpectedly, Terns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Terns Pharmaceuticals will offset losses from the drop in Terns Pharmaceuticals' long position.| Ventyx Biosciences vs. Arcellx | Ventyx Biosciences vs. Immunocore Holdings | Ventyx Biosciences vs. Vaxcyte | Ventyx Biosciences vs. Nuvalent |
| Terns Pharmaceuticals vs. Lyra Therapeutics | Terns Pharmaceuticals vs. Hookipa Pharma | Terns Pharmaceuticals vs. Cingulate Warrants | Terns Pharmaceuticals vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |